USSTOCK.TODAY
After-Market
Log in Sign up

Wells Fargo names Anaxon top biotech pick

Investing.com · ·by G4L

WFC Wells Fargo & Co
$85.76 -0.05%
View chart & analysis →
ANNX ANNX -5.25%
  1. 1Wells Fargo maintained a $27.00 price target for Anaxon, Inc. and named it a top biotech pick.
  2. 2Anaxon secured a credit facility of up to $200 million with Oxford Finance in August.
  3. 3Meta infrastructure head Santosh Janardhan will step down in early 2027.

So what's the key point?

Wells Fargo selected Anaxon as its most recommended biotech company. This follows the company securing $200 million in funding.

Source Investing.com · View original ↗

Related 3-line summaries

Major Banks Release Q3 Earnings and Key Metric Analysis The Motley Fool +1 · Oct 29Family conflicts and asset transfer issues due to lack of shared inheritance planning Fortune · Oct 27North American M&A Advisory Market: Goldman Sachs Leads in Deal Value, Houlihan Lokey Leads in Deal Count Private Banker International +4 · Oct 26
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news